Ovid Application Error
Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain.
Jimenez-Yuste, V. 1; Nunez, R. 2; Romero, J. A. 1; Montoro, B. 3; Espinos, B. 4
19(6):841-846, November 2013.
(Format: HTML, PDF)